Siemens Healthineers AG: Disclosure pursuant to art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) no. 596/2014 (MAR) and Art. 2 para. 3 of the Delegated Regulation (EU) No. 2016/1052

·2-min read

DGAP-News: Siemens Healthineers AG / Key word(s): Share Buyback
25.01.2021 / 17:16
The issuer is solely responsible for the content of this announcement.

Disclosure pursuant to art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) no. 596/2014 (MAR) and Art. 2 para. 3 of the Delegated Regulation (EU) No. 2016/1052

Share buyback - 8th Interim Reporting

In the time period from and including 18 January 2021 until and including 22 January 2021, a number of 131,964 shares of Siemens Healthineers AG were bought back within the framework of the share buyback of Siemens Healthineers AG; on 03 October 2020, Siemens Healthineers AG disclosed pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014 (MAR) and Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052 the start of the share buyback on 07 October 2020.

Shares were bought back as follows:

Day of purchase

Aggregated volume of shares

Weighted average price

01/20/2021

27,411

44.4576

01/21/2021

55,082

44.6668

01/22/2021

49,471

44.5061

 

The transactions are published in a detailed form on the website of Siemens Healthineers AG (www.corporate.siemens-healthineers.com/investor-relations).

The total volume of shares which were bought back within the framework of the share buyback in the time period from and including 07 October 2020 until and including 22 January 2021 amounts to 3,487,877 shares.

The purchase of the shares of Siemens Healthineers AG is carried out by a credit institution that has been commissioned by Siemens Healthineers AG; the shares are repurchased exclusively on the electronic trading platform of the Frankfurt Stock Exchange (XETRA).

Munich, 25 January 2021

Siemens Healthineers AG
The Managing Board


25.01.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:

English

Company:

Siemens Healthineers AG

Henkestr. 127

91052 Erlangen

Germany

Phone:

+49 800 188 188 5

Fax:

+49 9131 844552

E-mail:

contact@healthcare.siemens.com

Internet:

https://www.corporate.siemens-healthineers.com

ISIN:

DE000SHL1006

WKN:

SHL100

Indices:

MDAX, TecDAX

Listed:

Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange

EQS News ID:

1163093


 

End of News

DGAP News Service

show this
show this